-
FDA Approves Diagnostic Label Expansion for HR+, HER2–Ultra-Low Metastatic Breast Cancer
01 Feb 2025 14:15 GMT
… metastatic HR+, HER2-low, or HER2-ultra-low breast cancer.1,2
Previously … indications, which include patients with HER2+ breast cancer.2
“Endocrine therapy is … for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression …
-
Nanoparticles Modulating the Immune Microenvironment in Breast Cancer Treatment
01 Feb 2025 10:18 GMT
… breast tumor treatment.66,67 Therefore, nanoparticle-based combination therapies represent promising breast cancer … HER2-positive primary breast cancer: a multicenter Phase II clinical trial (PerSeUS-BC04). Breast Cancer …
-
Breast Cancer Didn't Delay This World Traveler
01 Feb 2025 06:09 GMT
… Hurst diagnosed an early-stage HER2-negative, estrogen-driven tumor … patients with early-stage breast cancer are candidates for breast- … chemotherapy.
“We treat breast cancer one patient at a … evaluation and diagnosis of breast cancer—under the care of …
-
Datopotamab Deruxtecan Wins CHMP Positive Opinion for Previously Treated HR+ Breast Cancer
31 Jan 2025 23:08 GMT
… metastatic hormone receptor–positive, HER2-negative breast cancer who have previously received … with metastatic HR positive, HER2-negative breast cancer,” Ken Takeshita, MD, … treated metastatic HR positive HER2 negative breast cancer. News release. Daiichi …
-
Novartis' Kisqali off to 'very rapid' launch in early breast cancer, CEO says. Can it keep up the momentum?
31 Jan 2025 22:56 GMT
… of HR-positive, HER2-negative early breast cancer in September, Novartis’ … rapid launch” in early breast cancer, Novartis CEO Vas Narasimhan … market share in early breast cancer within three months of … showing in first-line breast cancer.
“I do believe …
-
Ribociclib Plus Adjuvant Endocrine Therapy Is Safe, Tolerable in Patients With HR+/HER2– Breast Cancer
31 Jan 2025 22:16 GMT
… receptor 2-negative (HER2–) breast cancer (BC). The findings … receptor-positive/HER2– breast cancer (LEADER). npj Breast Cancer. January 7, … women with advanced breast cancer (MONALEESA-2). … with HR+/HER2- early breast cancer (NATALEE). ClinicalTrials …
-
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
31 Jan 2025 21:47 GMT
… epidermal growth factor receptor 2 (HER2)-negative breast cancer.
The Trop-2-directed …
-
Lerociclib/Fulvestrant Improves PFS, Tolerability in HR+/HER– Breast Cancer
31 Jan 2025 20:07 GMT
… [HR-positive/HER2-negative advanced breast cancer] whose disease had progressed … HR+/HER2− locally advanced or metastatic breast cancer who have progressed … fulvestrant for HR+ HER2- locally advanced or metastatic breast cancer. ClinicalTrials.gov. …
-
The Expanding Role of CDK 4/6 Inhibitors in Breast Cancer Treatment
31 Jan 2025 18:18 GMT
… positive (HR+)/HER2 negative (HER2–) metastatic breast cancer (MBC), CDK 4… /HER2-positive metastatic breast cancer. Presented at: San Antonio Breast Cancer Symposium; … for HR+, HER2‒ metastatic breast cancer: phase 1b study. NPJ Breast Cancer. 2022; …
-
Pre-Operative Radiotherapy May Hamper Breast Cancer Immunotherapy
31 Jan 2025 10:40 GMT
… Breast Cancer Now, which also funds the Breast Cancer … breast cancer subtypes, with people with HER2-positive or triple negative breast cancer … everyone living with breast cancer.”
Reference: Yoneyama … in primary breast cancer following neoadjuvant radiation …
About
© 1995-2025